All news

Warrants for 293,419 shares count toward a reported IRulya Therapeutics (IRLA) stake.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

SilverArc Capital Management, LLC and Devesh Gandhi have reported a 7.9% beneficial ownership stake in IRulya Therapeutics Inc. (IRLA), totaling 880,255 shares. This stake includes 586,836 common shares and 293,419 shares represented by exercisable warrants. The warrants have a 9.99% exercise limit to prevent the holder from exceeding that beneficial ownership percentage.

Read original source

IRLA company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.